Unknown

Dataset Information

Convection-enhanced drug delivery for glioblastoma: a review.


ABSTRACT:

Introduction

Convection-enhanced delivery (CED) is a method of targeted, local drug delivery to the central nervous system (CNS) that bypasses the blood-brain barrier (BBB) and permits the delivery of high-dose therapeutics to large volumes of interest while limiting associated systemic toxicities. Since its inception, CED has undergone considerable preclinical and clinical study as a safe method for treating glioblastoma (GBM). However, the heterogeneity of both, the surgical procedure and the mechanisms of action of the agents studied-combined with the additional costs of performing a trial evaluating CED-has limited the field's ability to adequately assess the durability of any potential anti-tumor responses. As a result, the long-term efficacy of the agents studied to date rema

SUBMITTER: D'Amico RS 

PROVIDER: S-EPMC8034832 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature